Connect
← Return to Blood sugar levels and cancer cell growth
Discussion
Blood sugar levels and cancer cell growth
Prostate Cancer | Last Active: 4 days ago | Replies (22)Comment receiving replies
@gently said “ Clinical trial are why ADT is so commonly advised.”
I’m wondering if you really meant to say this. ADT is advised for almost everybody who has prostate cancer that is advanced or has Recurred. Most people never even hear about clinical trials at that point.
I’m not sure where clinical trials are involved in ADT decisions.
Your thoughts!
Replies to "@gently said “ Clinical trial are why ADT is so commonly advised.” I’m wondering if you..."
Connect
jeffmarc, hi.
I see the distinction and appreciate your engagement.
More correctly stated, "Where"ADT is commonly advised in early stages of prostate cancer it is because of the clinicals." The recent work of Amir Kishan (UCLA) is widely known in advanced cancer centers in the US.
The advice for two months of ADT before treatment of intermediate, ADT sensitive prostate cancer was consistent with both surgical oncologist and radiation oncologist both proton and photon, with a four to six month duration. Between Lupron and Orgovyx the advice was mixed.
I'm unfamiliar with ADT advice for advanced or recurrent prostate cancer,
but assume the trials are influencial in determining which androgen deprivation agent is prescribed and in which combination. Newer agents like orgovyx are subject to clinicals.
In somatic testing on whether the tumor involved is androgen sensitive, the clinical trials have been crucial.